FRANKLIN LAKES, N.J. — Medical supply manufacturer BD has released a syringe with a shorter needle designed to reduce discomfort in patients with diabetes who must inject insulin, the company said Tuesday.
BD announced the introduction of the ultra-fine 6mm needle, saying more than 80% of patients expressed a preference for it in trials, and a recent article published by the American Association of Diabetes Educators recognized the safety and efficacy of shorter needles.
The needle is designed to deliver insulin subcutaneously in adults and children.
Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.